Inventor · disambiguated record
Bradley Tait
Also filed as: TAIT BRADLEY · TAIT BRADLEY D · TAIT BRADLEY DEAN
40 granted patents·22 pending applications·486 citations·filing 1990–2024
98Inventor score
Files withPROTEOSTASIS THERAPEUTICS INC17WARNER LAMBERT CO17FREQUENCY THERAPEUTICS INC11PROTEGO BIOPHARMA INC5KINETA INC3
Top patents by PatentIndex Score
62 records- 0197US9745292B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 29, 2017·14 cites·26 claims
- 0296US10017503B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted Jul 10, 2018·11 cites·28 claims
- 0396US9790219B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Oct 17, 2017·16 cites·38 claims
- 0494US5789440A5,6-dihydropyrone derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1994·Granted Aug 4, 1998·48 cites·25 claims
- 0590US11242361B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·2 cites·34 claims
- 0690US10174014B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Jan 8, 2019·9 cites·25 claims
- 0787US10392378B2Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 27, 2019·7 cites·8 claims
- 0887US10392372B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 27, 2019·6 cites·11 claims
- 0986US10344023B2Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Jul 9, 2019·6 cites·20 claims
- 1086US5936128A5,6-dihydropyrone derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1998·Granted Aug 10, 1999·28 cites·1 claims
- 1184US11746098B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·1 cites·25 claims
- 1284US5808062APyrone derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1994·Granted Sep 15, 1998·24 cites·30 claims
- 1383US5972980AMethod for treating and preventing inflammation and atherosclerosisWARNER LAMBERT CO·Filed 1996·Granted Oct 26, 1999·71 cites·2 claims
- 1483US5510375ACoumarin derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1993·Granted Apr 23, 1996·25 cites·8 claims
- 1582US5840751A5,6-dihydropyrone derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1994·Granted Nov 24, 1998·21 cites·23 claims
- 1681US9556166B2Proteostasis regulatorsFOLEY MEGAN·Filed 2012·Granted Jan 31, 2017·8 cites·5 claims
- 1781US5389682AAgents acting at cholecystokinin receptorsWARNER LAMBERT CO·Filed 1993·Granted Feb 14, 1995·17 cites·6 claims
- 1879US10738040B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2018·Granted Aug 11, 2020·1 cites·23 claims
- 1979US5504104ATricyclic pyrone derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1993·Granted Apr 2, 1996·19 cites·10 claims
- 2078US5331006AAmino acid analogs as CCK antagonistsWARNER LAMBERT CO·Filed 1991·Granted Jul 19, 1994·21 cites·24 claims
- 2176US11958873B2Proteasome activity enhancing compoundsKINETA INC·Filed 2021·Granted Apr 16, 2024·0 cites·35 claims
- 2276US10738011B2Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 11, 2020·1 cites·4 claims
- 2376US6512006B1HIV protease inhibitorsWARNER LAMBERT CO·Filed 2000·Granted Jan 28, 2003·10 cites·20 claims
- 2475US11066419B21H-pyrrole-2,5-dione compounds and methods of using sameFREQUENCY THERAPEUTICS INC·Filed 2017·Granted Jul 20, 2021·1 cites·35 claims
- 2575US5149709AInhibitors of acyl-coenzyme A: cholesterol acyl transferaseSCHERING CORP·Filed 1990·Granted Sep 22, 1992·11 cites·16 claims
- 2674US5834506ADihydropyrones with improved antiviral activityWARNER LAMBERT CO·Filed 1997·Granted Nov 10, 1998·14 cites·23 claims
- 2771US2024116894A1Proteasome activity enhancing compoundsKINETA INC·Filed 2023·Application pending·0 cites
- 2870US6046355ADihydropyrones with improved antiviral activityWARNER LAMBERT CO·Filed 1998·Granted Apr 4, 2000·11 cites·1 claims
- 2969US11098035B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2019·Granted Aug 24, 2021·0 cites·2 claims
- 3069US6103761AAgents acting at cholecystokinin receptorsWARNER LAMBERT CO·Filed 1994·Granted Aug 15, 2000·9 cites·13 claims
- 3169US6001866AMethod for treating and preventing inflammation and atherosclerosisWARNER LAMBERT CO·Filed 1996·Granted Dec 14, 1999·36 cites·11 claims
- 3268US12180189B2Proteostasis regulatorsKINETA INC·Filed 2019·Granted Dec 31, 2024·0 cites·10 claims
- 3368US10383881B21,5-dihydro-2H-pyrrol-2-one compounds and methods of using sameFREQUENCY THERAPEUTICS INC·Filed 2017·Granted Aug 20, 2019·1 cites·39 claims
- 3467US2024199577A1Acoramidis analogs for stabilizing transthyretin and inhibiting transthyretin misfoldingPROTEGO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3566US2024190831A1Transthyretin stabilizing compoundsPROTEGO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3665US6005103APyrone derivatives as protease inhibitors and antiviral agentsWARNER LAMBERT CO·Filed 1994·Granted Dec 21, 1999·17 cites·19 claims
- 3765US2024051960A1Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosisPROTEGO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3861US2024092757A1HETEROARYL DIAMIDE IRE1/XBP1s ACTIVATORSPROTEGO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3960US2021300948A11h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cellsFREQUENCY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4058US6927217B2HIV protease inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Aug 9, 2005·1 cites·12 claims
- 4158US6528510B1HIV protease inhibitorsWARNER LAMBERT CO·Filed 1999·Granted Mar 4, 2003·13 cites·33 claims
- 4257US2025129067A1Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereofPROGENTOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4355US10532996B2Proteostasis regulatorsPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted Jan 14, 2020·0 cites·5 claims
- 4455US2005075390A1HIV protease inhibitorsAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 4554US2023287021A1Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfoldingPROTEGO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4654US2018147187A1Compounds, compositions, and methods for increasing cftr activityPROTEOSTASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4752US2022127568A1Compositions and methods for generating hair cells by inhibiting epigenetic targetsFREQUENCY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4852US2022192984A1Pharmaceutical compositions comprising otic therapeutic agents and related methodsFREQUENCY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4951US6852711B2HIV protease inhibitorsAGOURON PHARMA·Filed 2002·Granted Feb 8, 2005·0 cites·11 claims
- 5050US5326762AInhibitors of acyl-coenzyme A: cholesterol acyl transferaseSCHERING CORP·Filed 1992·Granted Jul 5, 1994·3 cites·10 claims
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bradley Tait files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →